3C Farms: Maximizing the Entourage Effect

3C Farms has been providing SoCal with its classic homage to great OG Kush and a variety of other strains for essentially 20 years. After navigating the regulatory hurdles of 2018, 3C Farms now finds itself a top-shelf mainstay across the world’s largest cannabis market in Southern California after they expanded into tons of new storefronts. Backed by good genetics and a driven team, President of Sales and Director of Operations Waylon Broussard sat down with us to tell the full tale of 3C’s success.

Broussard got his earliest peek at the cannabis industry on a road trip through Northern California’s prime cultivation region in the Emerald Triangle with his dad. During this trip he smoked pot with his dad for the first time.

3C Farms’s Chardonnay.

“That was the highest I’ve ever been,” said Broussard.

In 2006, Broussard opened Cali’s Finest Compassion Co-op with his cousin. At the same time, Bryan Schwartz founded 3C (Schwartz remains the master cultivator at 3C Farms to this day). In the decade prior to the 3C brand’s official founding with proper paperwork in 2014, the operation was essentially a medical effort.

From the beginning, solid genetics served as the core of 3C’s success — helped out by the fact that Schwartz’s cousin is Josh D of OG Kush fame.

“When Josh came back in 1996 from Florida, he brought the original OG strain over here, which is our Club 33 OG,” Broussard said. “He gave that to [Schwartz] back in 1996 and he’s been growing it in the [San Fernando] Valley ever since.”

The canopy in 3C’s growroom bursts with color.

The Club 33 is the essential representation of what people think of when they think of exceptional Southern California OG Kush. It oozes all of the flavors, aromas and impact that made the strain famous in the first place. It would be expanded upon further generations like the Enoch and Illuminati OG.

In 2014, after working together previously, Broussard and Schwartz teamed up bringing 3C under the Coast to Coast Collective flag, with the help of another co-founder Chris Malcolm, who also serves as Coast to Coast Collective’s CEO these days. As Broussard puts it, the team used Cali’s Finest Compassion Co-op’s permit to put 3C on the books. 3C and its partners now has two pre-ICO LA dispensaries with full cultivation grandfathered in. “Pre-ICO” is a special designation meaning those locations were open before the LA Interim Control Ordinance (ICO) established a temporary moratorium on opening new dispensaries in September 2007.

The 3C team collaborates with legendary cultivator Josh D (right).

In this new wave of licensing, 3C has found itself able to put the product on the shelves in various new locations, but the last couple years haven’t been without their hiccups in terms of dealing with California’s regulatory hurdles.

“That’s been a challenge,” said Broussard. “I can’t say any one of us did it ourselves. The best part about that was having a great team behind 3C from our investors to our board of directors. It’s been a fun road, definitely challenging.”

One of the biggest problems has been the constantly evolving regulatory framework of Los Angeles. Broussard says it’s hard to make smart business decisions when things like packaging or testing might change in any given month as far as one knows.

Despite all the regulatory upheaval, 3C is now available in a spread of LA dispensaries. One of the big reasons behind their reach is their wide distribution of genetics bred in-house.

“We do all of our own crossbreeding, obviously,” said Broussard, again pointing to the lineage of their stock. “From there, we share genetics. I did a trade with my boy Kevin over at Moxie for their AC/DC for our Casey Jones. Our new strain A3/DC has been very popular.”

3C’s take on AC/DC comes in at a 20 to 1 CBD to THC ratio. They’ve also released AC/OG in 2018, which is a 2 to 1 ratio made from Illuminati OG crossed with AC/DC. With the current rise in CBD enthusiasm, the fact that breeders like 3C are expanding that area of the cannabis genome is essential.

Another popular 3C strain is Chardonnay. It pairs 3C’s Kraken line with Berry Noir. Broussard says the Berry Noir has a very Blackberry Kush feel to it. The Kraken lineage included Harlequin and 3C’s Conspiracy Kush.

“It’s kind of a trip for me, as to where I thought that strain came from,” Broussard said. “We ran a Phylos Bioscience test and a lot of the markings on that one would come back as a Blue Dream. So [Chardonnay has] been a really fun sativa-dominant hybrid for us, when that’s really not what we were originally going for.”

Broussard believes the success in the breeding program has come down to 3Cs’ efforts to maximize “the entourage effect,” the name for how all the plant’s cannabinoids and terpenes interact with each other to produce a complex effect on the body.

“We’ve always tried to keep the entourage effect with our strains so you’ll see higher levels of CBN and higher levels of CBD in our strains — really it’s more than just a THC thing,” he said. “Even before the testing was out there, people just love the feeling they got from smoking 3C.”

3C has been growing in Southern California for about 20 years, and has successfully transitioned into the regulated market.

We asked Broussard if the last four
years of preparation made it easier for 3C to fight off the bigger corporate
players attempting to grab a chunk of California’s legal cannabis market.

“Definitely in brand recognition, and of course, quality,”
said Broussard. “3C Farms stands for craft cannabis cultivation. We coined that
a long time ago to remind us what we do.”

Broussard said people just need to realize there was always
going to be a place for those larger competitors, resource-wise, as the market expanded.
Broussard describes it as the same thing we see in the beer industry, with small
craft brewers surviving at the same time as larger corporations like
Anheuser-Busch.

“We’ve always gone after the craft market,” Broussard said. “It’s always indoor, hand-trimmed, hand-cured, everything we do we haven’t used any other machinery. “

TELL US, have you ever tried cannabis from 3C Farms?

Originally published in the print edition of Cannabis Now. LEARN MORE

The post 3C Farms: Maximizing the Entourage Effect appeared first on Cannabis Now.

Monday, August 26, 2019 Headlines | Marijuana Today Daily News

Marijuana Today Daily Headlines
Monday, August 26, 2019 | Curated by host Shea Gunther

// Whole Cannabis Flower Relieves Pain More Than Other Weed Products, Study Shows (Merry Jane)

// Five months after opening, Brookline’s marijuana store is still one of America’s busiest – and not everyone is thrilled (Boston Globe)

// Chocolate Complicates Marijuana Edibles Potency Testing, Scientists Find (Marijuana Moment)


Today’s headlines are brought to you by our friends over at Eaze.com, California’s top one stop website for legal marijuana delivery. If you live in the golden state, swing over to Eaze.com to see if they are active in your area. With deliveries taking place in less than an hour, it’s never been easier to get legal California marijuana delivery. And of course, if you don’t live where Eaze delivers, you can still benefit from all the useful bits of industry insight and analysis they’ve developed using their properly aggregate and anonymized sales data stream.


// ‘We’ve put ourselves on the map’: Thousands flock to Oklahoma City for High Times Cannabis Cup (Tulsa World)

// Floridians overwhelmingly support legalizing recreational marijuana, top pollster finds (Florida Politics)

// California Says Its Cannabis Revenue Has Fallen Short Of Estimates, Despite Gains (Oregon Public Broadcasting)

// Pot Vape Race Heats Up as Store Count Grows: Cannabis Weekly (Bloomberg)

// Massachusetts Department of Revenue can withhold data on local marijuana tax distributions, state rules (Mass Live)

// Dixie Elixirs CEO Talks Partnership With AriZona Iced Tea and More (Denver Westword)

// Buttigieg Pledges To Decriminalize Possession Of All Drugs In First Term As President (Marijuana Moment)


Check out our other projects:
Marijuana Today— Our flagship title, a weekly podcast examining the world of marijuana business and activism with some of the smartest people in the industry and movement.
Marijuana Media Connect— A service that connects industry insiders in the legal marijuana industry with journalists, bloggers, and writers in need of expert sources for their stories.

Love these headlines? Love our podcast? Support our work with a financial contribution and become a patron.

Photo: Oregon Department of Agriculture/Flickr

Standardized Cannabis Medicine – The ‘Responsibility Of All In The Industry’

Creating standardized medicine is the gold standard for the cannabis industry but the nature of the plant can make this difficult, attendees to Cannabis Europa heard.

Some panelists argued that attempts by the major pharmaceutical companies to patent drugs from the cannabis plant should be challenged. Others said that for cannabis medicine to achieve globally accepted standards there would need to be an involvement from the pharmaceutical giants to fund the research.

Dr Barbara Pacchetti, of U.K. company EMMAC Life Sciences, described cannabis as an ‘unconventional medicine’. “The aim is for standardized cannabis medicine, and this would be the peak of Everest. Doctors are not comfortable with anything else, but with cannabis we have the plant’s entourage effect and this leads to a lot of questions and grey areas in relation to variability.

“For pharma companies, isolates are the gold standard, but there is variability with cannabis due the to the different cannabinoids, plant strains, the terpenes and the flavonoids and this means we have to do more work to understand this entourage; the genetics.”

Speaking on day one of the the conference in a debate on ‘Cannabis-Based Medicines’ she said it would initially be difficult to bridge the gap left by a lack of research, due to the prohibition of cannabis over the last 60 years. And she added: “We are just the beginning to learn and to connect with regulators, the health authorities and this will allow us to make the right cannabis medicines available to the public.”

standardized cannabis medication

Creating consistent medications is a challenge in the cannabis industry

Dianna Gutierrez, of Spanish firm Linneo Health, agreed there was much research to be done. She said the company was looking at selecting different cannabis molecules and products to target different diseases. She added: “We have to change way we produce, grow and manufacture a medicine and we need the money; huge investment from funds to get the quality of drug we require.”

Aras Azadian, of Canadian company Avicanna, said physicians like to have straight-forward medicines they can rely on, and this is a challenge the cannabis industry can rise to.

“They depend on one or two, high-standard products. When prescribing it’s a case of taking it in stages – crawl, walk, run – but patients may see things differently and want different strains and flowers, for example. Patients have become accustomed to having the same level of consistency in their medicines, but the variability of the cannabis plant makes this difficult to achieve.

“Cannabis medicine needs to have the highest standards; Quality assurance, and standardization of cannabis medicine is necessary, achievable, and the responsibility of the people in this room.”

In a separate panel discussion on day two of the conference Prof Mike Barnes, chairman of the U.K. Medical Cannabis Clinicians’ Society argued that attempts to patent elements of the cannabis plant – something U.K. firm GW Pharmaceuticals has successfully achieved – is bad news for patients, as it increases the price of the drugs. He went on to say these patents should be challenged, when granted. 

However, Dean Billington of Brains Bioceuticals argued that the patenting route to market for a drug – including cannabis drugs – is necessary to fund the research. 

The post Standardized Cannabis Medicine – The ‘Responsibility Of All In The Industry’ appeared first on CBD Testers.

Here’s What You Need To Know About CBD Terpsolate

With cannabis legalization taking hold across North America and other parts of the world, it’s sometimes hard to keep up with all the new innovations that are being sold. Terpsolates are one such product that’s a cut above the rest.

Many people know about Sativa and Indica – the two primary varieties of cannabis that are similar but differ slightly in effects. There are also a bunch of different ways to take cannabis and hemp these days, other than smoking joints or pipes in the form of combustion.

Many people who use cannabis or hemp, either medically or recreationally, choose to take it in edible form. Others prefer to vape it in dry flower vaporizers, while some opt for specially formulated E-juice which is also fit for the purpose. But those who want to take things to the next level opt for Terpsolates.

Terpsolates might sound a bit intimidating as the name seems so scientific, but they are not. A Terpsolate is simply a CBD isolate which has specific Terpenes from the cannabis or hemp plant reintroduced and mixed with it. This means the user enjoys the unique flavor of cannabis and also benefits from the medicinal effects that CBD (short for cannabidiol) offers.

These isolates were created for people who want to feel good from cannabis but don’t want to feel high, stoned, or disoriented. Regular CBD extract, known as “full spectrum CBD oil” has the medicinal CBD inside as the name suggests but doesn’t contain the terpenes. The terpenes give flavor and a more full-bodied experience, especially when taken in the right concentrations together with CBD. 

Terpsolate is made by infusing an isolated CBD solution with Terpenes. Standard CBD oil, however, contains other terpenes and cannabinoids which extract naturally along with the CBD. This is an issue for some people who want only to take isolated CBD with specific terpenes and not with other cannabis compounds so Terpsolate is considered to be CBD in its purest form (with Terpenes).

CBD isolate is made by putting cannabis or hemp plants through an extraction process called supercritical CO2 extraction. This leaves out any solvents from the process and uses carbon dioxide at high temperatures for the purest method of extraction known to man. The mixture is then placed into cool oil, such as coconut or hemp seed oil before it goes through two more steps – winterization and short path distillation.

At this stage, this is full spectrum CBD Oil and not a Terpsolate. Filtration and winterization then take place, whereby the mixture is filtered to catch chemical compounds other than CBD. The final product is then “Winterized” or frozen, and then specific Terpenes can be extracted at different thawing temperatures or left in as desired by the manufacturer, which is known as short path distillation.

Terpsolates are in truth the purest form of CBD and Terpenes on the market. Something called the “Entourage Effect” takes place when cannabis isolates like CBD mix with specific Terpenes to offer a stronger and more satisfying experience. Essentially, Terpsolates are designed for connoisseurs or those with particular needs.

If pure CBD and Terpenes are your thing, Terpsolates are the perfect solution for you, especially if you want to be sure that zero THC is included in the mix. That’s one of the main reasons why Terpsolates are becoming more and more popular these days as people begin to realize they have a wide choice of tailor-made cannabis products at their disposal.

Always ensure that the Terpsolate you are interested in goes through the CO2 extraction process as stated above and is backed up by bonafide third-party lab test results. These test results offer customers peace of mind, safe int he knowledge that the product they’re taking is safe and fit for use. 

The post Here’s What You Need To Know About CBD Terpsolate appeared first on CBD Testers.